The head of the Agency for Medicines and Medical Devices, Eremei Priseajniuc, signed authorization this Friday to import 5,000 vials of Remdesivir, the first drug authorized in the US and the EU for the treatment of COVID-19 virus.
According to the Medicines and Medical Devices Agency representatives, the Remdesivir batch, with the trade name Desrem, produced by the pharmaceutical company Mylan, the Netherlands, is imported by Tetis International CO SRL scheduled to arrive in Chisinau soon.
In Moldova, the preparation Remdesivir is provided in the Provisional National Clinical Protocol “New type coronavirus infection,” used to treat patients infected with the SARS VOC-2 virus.
On September 8, the Agency for Medicines and Medical Devices authorized the first import of about 2,000 vials of Remdesivir, under the trade name Covifor.
On October 7, the European Commission announced the agreement with the American pharmaceutical company Gilead, purchasing more than 20,000 additional doses of Remdesivir, thus trying to cover the supply of the antiviral drug that the European Union states are facing.